Key result
Multifactorial cardiometabolic risk factor management may substantially curb CVD and yield cost savings in T2D.
Why the study?
The impact of multifactorial risk factor control on 3-year incidence of fatal/non-fatal cardiovascular disease and healthcare costs in Asian patients with type 2 diabetes was evaluated using simulation.
Does simulated multifactorial risk factor control reduce the incidence of cardiovascular disease and healthcare costs in Asian patients with type 2 diabetes?
Observational (n=103,958)
Yes
Does simulated multifactorial risk factor control reduce the incidence of cardiovascular disease and healthcare costs in Asian patients with type 2 diabetes?
Answers are grounded in this paper and cite their sources.
Simulated multifactorial management of cardiometabolic risk factors in Asian patients with type 2 diabetes could substantially reduce the 3-year incidence of cardiovascular disease and associated healthcare costs.
Aims We evaluated the impact of scenario‐based multifactorial control on the 3‐year incidence of fatal/non‐fatal cardiovascular disease (CVD) and associated healthcare costs in Asian patients with type 2 diabetes (T2D). Materials and Methods We applied the validated ‘ABC’ model to simulate the 3‐year impact of attaining multiple treatment targets (HbA 1c < 7%, blood pressure [BP] < 130/80 mmHg, risk‐stratified LDL‐C target [ABC], smoking cessation and weight reduction) on the incidence of fatal/non‐fatal CVD (ischaemic heart disease and stroke) in patients with T2D enrolled from 11 Asian countries/jurisdictions in the Joint Asia Diabetes Evaluation (JADE) Register. We estimated the costs of these simulated CVD events and potential cost savings with multifactorial intervention. Results Amongst 103 958 patients with T2D (53.4% men, 12.0% current smokers, mean [SD] age 57.6 [11.8], HbA 1c 7.96 [1.87], systolic BP 132.0 [17.4] mmHg, LDL‐C 2.6 [0.95] mmol/L, BMI 26.2 [4.5] kg/m 2 ), 17 151 (16.5%) had prior CVD and 86 807 (83.5%) had no CVD at baseline. In the CVD group, 1.5% achieved all three ABC targets and 5.1% in the nonCVD group at baseline. In the CVD group, the estimated incidence rate for CVD was 61.60 per 1000‐person‐years (PY), and 11.65 per 1000‐PY in the non‐CVD group. Simulated achievement of all three ABC targets reduced the incidence rates by 35.1%–40.01% per 1000‐PY in the CVD group and by 30.2%–8.13% per 1000‐PY in the non‐CVD group. In China, these scenario‐based simulations might avert 1 177 682 CVD events per year with a potential saving of US$ 11 292 823 476. Conclusions Multifactorial management of cardiometabolic risk factors may have a substantial impact on CVD prevention, with cost savings in patients with T2D.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2026) conducted an observational in Type 2 diabetes (n=103,958). Simulated achievement of HbA1c, blood pressure, and LDL-C targets vs. Current baseline risk factor control was evaluated on 3-year incidence of fatal/non-fatal cardiovascular disease (ischaemic heart disease and stroke). Simulated achievement of multifactorial treatment targets reduced the incidence of cardiovascular disease by 35.1% in patients with prior CVD and by 30.2% in those without prior CVD.
Synapse has enriched 10 related papers. Consider them for comparative context: